Furthermore, cluster of differentiation 36 (CD36), an integral transmembrane glycoprotein, prompted mTOR-mediated oncogenic glycolysis via activation of the PI3K/AKT signaling axis in HCC [55] (Figure 1). This evidence concerns the gene AKT1 and hepatocellular carcinoma.